IGFBP- 3 reduceres hos patienter med svær primær IGFD, hvilket resulterer i en øget IGF- 1- clearance hos disse personer i forhold til raske personer.
IGFBP-3 is reduced in subjects with severe Primary IGFD, resulting in increased clearance of IGF-1 in these subjects relative to healthy subjects.